Skip to main content
. Author manuscript; available in PMC: 2023 Oct 1.
Published in final edited form as: Lancet HIV. 2022 Oct;9(10):e700–e708. doi: 10.1016/S2352-3018(22)00219-3

Table 1.

Descriptive characteristics of person-years contributed in the study population of people living with HIV in the United States over time.

Characteristic 2001–2004 2005–2008 2009–2012 2013–2016
Age group
20–39 284,608 (38·3%) 356,772 (30·4%) 425,480 (26·9%) 235,996 (29·1%)
40–49 299,321 (40·3%) 474,044 (40·5%) 567,403 (35·8%) 237,153 (29·2%)
50–59 126,515 (17·0%) 263,486 (22·5%) 433,146 (27·3%) 238,148 (29·3%)
60–69 27,181 (3·7%) 64,188 (5·5%) 131,154 (8·3%) 82,998 (10·2%)
70+ 5,596 (0·8%) 13,284 (1·1%) 26,699 (1·7%) 17,133 (2·1%)
HIV risk group
Male other / unknown 170,790 (23·0%) 278,085 (23·7%) 383,217 (24·2%) 182,494 (22·5%)
Female other / unknown 144,548 (19·4%) 251,947 (21·5%) 353,794 (22·3%) 172,893 (21·3%)
Male PWID 125,451 (16·9%) 161,431 (13·8%) 174,802 (11·0%) 73,602 (9·1%)
Female PWID 63,902 (8·6%) 81,726 (7·0%) 90,845 (5·7%) 37,853 (4·7%)
MSM 238,530 (32·1%) 398,584 (34·0%) 581,224 (36·7%) 344,585 (42·5%)
Race and ethnicity
Hispanic 187,475 (25·2%) 310,383 (26·5%) 399,103 (25·2%) 208,350 (25·7%)
Non-Hispanic Black 350,350 (47·1%) 556,115 (47·5%) 781,135 (49·3%) 377,419 (46·5%)
Non-Hispanic White 205,394 (27·6%) 305,275 (26·1%) 403,644 (25·5%) 225,660 (27·8%)
Time since HIV diagnosis*
<=5 260,425 (35·0%) 316,903 (27·5%) 337,306 (22·1%) 155,886 (21·3%)
5.01–10 226,406 (30·5%) 335,074 (29·1%) 416,349 (27·3%) 187,354 (25·6%)
10.01–15 108,513 (14·6%) 226,730 (19·7%) 315,264 (20·7%) 166,042 (22·7%)
>=15.01 years 17,332 (2·3%) 101,486 (8·8%) 272,829 (17·9%) 194,167 (26·5%)
Missing 130,544 (17·6%) 172,382 (15·0%) 183,578 (12·0%) 28,914 (3·9%)
Prior AIDS diagnosis*
No 262,460 (35·3%) 446,698 (38·8%) 632,278 (41·5%) 330,237 (45·1%)
Yes 480,759 (64·7%) 705,877 (61·2%) 893,049 (58·5%) 402,126 (54·9%)

PWID = persons who inject drugs

MSM = men who have sex with men

*

Numbers for HIV-related factors excluded Massachusetts